Evidence map›Paper›PMID 42137489›Full record

ArticleMDM policy & practice

Developing a Novel Values Elicitation Measure for Clinical Use in Older Adults with Hematologic Malignancies: Values-HM.

Daniel R Richardson, Allison M Deal, Carl J Mhina, Matthew Washko, Amy C Cole, Norah L Crossnohere, Kah Poh Loh, Ethan Basch, Stephanie B Wheeler, William A Wood and 3 more

Abstract read
In one paragraph

Article in MDM policy & practice. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Daniel R RichardsonUNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.ORCID https://orcid.org/0000-0001-9310-5773
Allison M DealUNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.
Carl J MhinaUniversity of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Matthew WashkoUniversity of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Amy C ColeUniversity of North Carolina at Chapel Hill, Chapel Hill, NC, USA.ORCID https://orcid.org/0000-0001-9478-6005
Norah L CrossnohereThe Ohio State University, Columbus, OH, USA.ORCID https://orcid.org/0000-0002-2811-1330
Kah Poh LohDivision of Hematology/Oncology, Department of Medicine, James P Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA.
Ethan BaschUNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.ORCID https://orcid.org/0000-0003-3813-9318
Stephanie B WheelerUniversity of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
William A WoodUNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.
John F P BridgesThe Ohio State University, Columbus, OH, USA.
Thomas W LeBlancDivision of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, NC, USA.
Antonia V BennettUniversity of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Highlights: Values-HM is a novel values elicitation measure designed based on best-worst scaling for adults with blood cancers.Values-HM appears to be acceptable to patients and may be valid and reliable to capture patient values in clinical care.

Indexed as

best-worst scalingDecision Making, SharedHematologic Neoplasmsolder adultsPatient PreferencePatient-Reported Outcome Measurestreatment decision makingvalues elicitation

Identifiers

PMID42137489
PMCPMC13167359

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.